Clinical trial
Optimal Antiplatelet Therapy for Chinese Patients With Coronary Artery Disease
NCT01735305 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimal Antiplatelet Therapy for Chinese Patients With Coronary Artery Disease
- Lead sponsor
- Shenyang Northern Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- March 31, 2015
- Enrollment
- 14,032 (actual)
- Sites
- 107
Conditions
As the registry lists them; a condition with its own page is linked.